Despite TELA Bio's high revenue growth, its P/S ratio barely...
Despite TELA Bio's high revenue growth, its P/S ratio barely aligns with industry median, indicating public skepticism about future growth. Its current stock price could be attractive, yet it shows two risk signs.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000264e369d978faf.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment